Nick Haining

CSO and co-founder of @ArsenalBio via @DanaFarber, @broadinstitute, and @Merck. He/his.

[Nick Haining @nickhaining]

I’m lucky that I get to work with this team.

[ArsenalBio @ArsenalBio]

We are excited to announce our $325 million #SeriesC financing. This new investment will enable ArsenalBio's ongoing development efforts and scale our manufacturing capabilities to develop T-cell medicines. We thank the new investors along with our existing investors for their support in helping us to achieve our goal to defeat cancer. #celltherapy #patientsfirst
https://t.co/AvXKn0UmOK

[Nick Haining @nickhaining]

@BrianC_Miller @UNC_Lineberger @ArsenalBio In the future I’m going to insist that everyone sings before I give a talk. It’s the only way, really.

[Nick Haining @nickhaining]

@MangusoLab @Nature @calico @abbvie Congratulations to the whole team across all the institutions on a huge advance chemically and therapeutically. More generally it suggests that long term funding of ambitious science partnered with with engaged drug hunters can make magic happen.

[Nick Haining @nickhaining]

@lucyatkins @DauntSummertown There in spirit xxx

[Nick Haining @nickhaining]

@UrnovFyodor @JohnDoench @MarsonLab The OG Weissogram in @MangusoLab ‘s paper https://t.co/bKeqdg6fBH

[Thomas Gardner @TJJardinero]

Proud to be one of said Braniacs! Looking forward to discussing our exciting work at #AACR2023

[Nick Haining @nickhaining]

There’s some really awesome science going on at ⁦@ArsenalBio⁩ — come and meet the brainiacs building tomorrow’s cell therapy today at #AACR23 https://t.co/28NTrVbIOx

[Nick Haining @nickhaining]

Well deserved award to a thoughtful and original scientist who has helped us all understand a lot about how T cells work and don’t work. Congrats @EJohnWherry !

[AACR @AACR]

We congratulate @EJohnWherry, of @PennMedicine on being recognized with the 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology. Learn more: https://t.co/5mNugSx8Ig @CancerResearch

[Nick Haining @nickhaining]

@shaleklab @MIT @ChemistryMIT @MIT_IMES @kochinstitute Well done, you clever sausage, you. Delighted.

[Nick Haining @nickhaining]

@drsam strong work

[Nick Haining @nickhaining]

@drsam I thinking wine, chocolate and antiquity but trains are good too.

[Nick Haining @nickhaining]

I’m so glad this experiment ended and was reported in my lifetime. Amazing.

[Masopust Vezys Lab @Masopust_Vezys]

Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimulation for over 10yrs! And produce enough progeny to occupy a volume 30,000x the Earth's volume! @Nature https://t.co/jPfmX2Ilrq

[Masopust Vezys Lab @Masopust_Vezys]

Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimulation for over 10yrs! And produce enough progeny to occupy a volume 30,000x the Earth's volume! @Nature https://t.co/jPfmX2Ilrq

[Nick Haining @nickhaining]

@IreneGhobrial @DanaFarber I think @BradEBernstein is often more alert than that. Although not always.

[Nick Haining @nickhaining]

Four years ago, the founders had a bunch of ideas on a whiteboard and not much else. Today, @ArsenalBio has dosed the first patient with AB-1015, an engineered autologous T cell therapy for ovarian cancer. Incredibly proud of what the Arsenal team has accomplished. Onwards.

[ArsenalBio @ArsenalBio]

The first patient has been dosed with AB-1015 in a Phase 1, first-in-human clinical trial for patients with ovarian cancer that is resistant to platinum-based regimens. It is our first internally discovered T cell medicine to enter clinical development: https://t.co/kRFz2a6iwX

[Nick Haining @nickhaining]

@VanAllenLab B+ Needs to be much more convoluted to be the work of an IRL immunologist

[Nick Haining @nickhaining]

@JohnDoench “Write a John Doench out-of-office auto reply, only funny”

[Nick Haining @nickhaining]

Be like Carl

[Nick Haining @nickhaining]

@oleg8r @MSKCancerCenter That’s a terrifying sight

[Nick Haining @nickhaining]

@facts___matter @NatImmunol @EJohnWherry @PennMedicine Love this story. Congratulations @facts___matter